Novartis Ag (NVS) Assets (2009 - 2026)
Novartis Ag (NVS) posted Assets of $122.03 billion for Q2 2026, up 16.9% from $104.4 billion a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag's Assets came in at $110.95 billion, up 8.5% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
- In prior years, Novartis Ag's Assets was $102.25 billion in FY2024 (+2.3%), $99.95 billion in FY2023 (-14.9%), $117.45 billion in FY2022 (-10.9%) and $131.8 billion in FY2021 (+3.1%).
- The Q2 2026 figure stands as the highest quarterly Assets since Q2 2022.
- On a year-over-year basis, Assets has increased in each of the last seven quarters, with growth averaging 6.9% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q1 2026, with growth of 18.6%; the weakest was Q1 2024, with a decline of 16.0%.
- According to Business Quant data, Assets for the three prior quarters was $118.53 billion (Q1 2026), $110.95 billion (Q4 2025) and $107.29 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.03 Bn |
| Mar 31, 2026 | 118.53 Bn |
| Dec 31, 2025 | 110.95 Bn |
| Sep 30, 2025 | 107.29 Bn |
| Jun 30, 2025 | 104.40 Bn |
| Mar 31, 2025 | 99.94 Bn |
| Dec 31, 2024 | 102.25 Bn |
| Sep 30, 2024 | 103.52 Bn |
| Jun 30, 2024 | 97.51 Bn |
| Mar 31, 2024 | 94.33 Bn |
| Dec 31, 2023 | 99.95 Bn |
| Sep 30, 2023 | 112.70 Bn |
| Jun 30, 2023 | 110.98 Bn |
| Mar 31, 2023 | 112.24 Bn |
| Dec 31, 2022 | 117.45 Bn |
| Sep 30, 2022 | 118.46 Bn |
| Jun 30, 2022 | 122.91 Bn |
| Mar 31, 2022 | 125.22 Bn |
| Dec 31, 2021 | 131.80 Bn |
| Sep 30, 2021 | 121.21 Bn |
API Access
Novartis Ag Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();